Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer have?
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer has 938 citations in the OpenAlex counts ScholarIQ stores.
When was Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer published?
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer has 2019 year in the ScholarIQ index.
What is the open-access status of Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer?
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer has bronze oa status in the ScholarIQ index.
What is the DOI of Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer?
The DOI for Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer is on the source record.
What is the PMID of Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer?
The PMID for Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer is on the source record.
What is the OpenAlex record for Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer?
The OpenAlex for Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer is on the source record.